Key facts
- It has raised $4.0M across 1 recorded rounds; the latest was Early Stage VC ($16.1M) in May 2026.
- Notable investors include Long Journey Ventures, Accomplice VC, Night Capital, Lance Armstrong, Retron — 12 tracked in total.
- Throne has filed 1 Form D with the SEC, most recently Jun 2026 ($16.1M sold to 47 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Throne
Funding rounds
1 roundsAbout Throne
Developer of a health monitoring device designed to monitor well-being from excretion waste. The company's device tracks the hydration of the person from their urine secretion and tracks the gut health from the comfort and privacy of their home, enabling users with round-the-clock monitoring and valuable but infrequent information about their body.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2023
- Employees
- 10
- Website
- thronescience.com/
- Ownership
- Privately Held (backing)
Throne doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Throne shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Throne in its N-PORT filings yet. We sweep new filings monthly.